Download Files:
VEGFR-2-IN-6
$350 – $2,500
Products Details
Product Description
– VEGFR-2-IN-6 (example 64) is a VEGFR2 inhibitor (angiogenesis modulator), which is extracted from patent WO 02/059110[1].
Web ID
– HY-131658
Storage Temperature
– -20°C, 3 years; 4°C, 2 years (Powder)
Shipping
– Room Temperature
Applications
– Cancer-Kinase/protease
Molecular Formula
– C20H21N7O2S
References
– [1]Glaxo Wellcome House, et al. PYRIMIDINEAMINES AS ANGIOGENESIS MODULATORS. Patent WO 02/059110.
CAS Number
– 444731-47-9
Molecular Weight
– 423.49
Compound Purity
– 99.27
SMILES
– O=S(C1=CC(NC2=NC=CC(N(C)C3=CC4=C(C=C3)C(C)=NN4)=N2)=CC=C1C)(N)=O
Clinical Information
– No Development Reported
Research Area
– Others
Solubility
– DMSO : 25 mg/mL (ultrasonic)
Target
– VEGFR
Pathway
– Protein Tyrosine Kinase/RTK
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
